Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Freie Universität Berlin has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 4 distinct examiners and 4 distinct art units, indicating a fully distributed set of current examination assignments.
GILL, RACHEL B is the busiest examiner, with 1 pending matter. Counsel should preserve separate prosecution strategies for each examiner and art unit while checking for recurring scientific or claim issues across the portfolio. The figures support centralized docket oversight, but not a single examiner-specific response approach.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| Multi-statute (no §101) | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GILL, RACHEL B | 1 | 65.4% | +28.8% |
| GODENSCHWAGER, PETER F | 1 | 68.2% | +17.5% |
| SHERMAN, ERIC SCOTT | 1 | 73.5% | +19.6% |
| BARRON, SEAN C | 1 | 52.7% | +30.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18730516 | LIVE ATTENUATED SARS-COV-2 AND A VACCINE MADE THEREOF | GILL, RACHEL B | — |
| 18728054 | ALKALI METAL METALATE COMPOUNDS WITH MAGNETIC EXCHANGE BIAS AND IONIC CONDUCTIVITY PROPERTIES | GODENSCHWAGER, PETER F | — |
| 18684109 | STORAGE MEDIUM FOR STORING HYDROGEN CHLORIDE AND METHOD FOR SEPARATING AND STORING HYDROGEN CHLORIDE HCL FROM HCL CONTAINING GAS | SHERMAN, ERIC SCOTT | — |
| 18574264 | METHOD FOR ACTIVATING DENDRITIC CELLS | BARRON, SEAN C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18730516 | LIVE ATTENUATED SARS-COV-2 AND A VACCINE MADE THEREOF | GILL, RACHEL B | — |
| 18728054 | ALKALI METAL METALATE COMPOUNDS WITH MAGNETIC EXCHANGE BIAS AND IONIC CONDUCTIVITY PROPERTIES | GODENSCHWAGER, PETER F | — |
| 18684109 | STORAGE MEDIUM FOR STORING HYDROGEN CHLORIDE AND METHOD FOR SEPARATING AND STORING HYDROGEN CHLORIDE HCL FROM HCL CONTAINING GAS | SHERMAN, ERIC SCOTT | — |
| 18574264 | METHOD FOR ACTIVATING DENDRITIC CELLS | BARRON, SEAN C | — |
| Art Unit | Apps |
|---|---|
| 1671 | 1 |
| 1767 | 1 |
| 1736 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18730516 | LIVE ATTENUATED SARS-COV-2 AND A VACCINE MADE THEREOF | GILL, RACHEL B | 1671 | §101§102§103§112DP | Non-Final OA | — | Pending | Jul 19, 2024 |
| 18728054 | ALKALI METAL METALATE COMPOUNDS WITH MAGNETIC EXCHANGE BIAS AND IONIC CONDUCTIVITY PROPERTIES | GODENSCHWAGER, PETER F | 1767 | §102§112 | Non-Final OA | — | Pending | Jul 10, 2024 |
| 18684109 | STORAGE MEDIUM FOR STORING HYDROGEN CHLORIDE AND METHOD FOR SEPARATING AND STORING HYDROGEN CHLORIDE HCL FROM HCL CONTAINING GAS | SHERMAN, ERIC SCOTT | 1736 | §102§103§112 | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18574264 | METHOD FOR ACTIVATING DENDRITIC CELLS | BARRON, SEAN C | 1653 | §103§112 | Non-Final OA | — | Pending | Dec 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFreie Universität Berlin has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Rachel B Gill has the most, with 1 of Freie Universität Berlin's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
